高流量鼻导管给氧疗法在合并艾森曼格综合征的新型冠状病毒肺炎中的作用：一例报告
Role of high-flow nasal oxygen therapy in COVID-19 pneumonia with Eisenmenger syndrome: A case report.
作者信息
Hehsan Muhammad Rafiqi, Hanafi Ahmad Dzarrin, Abidin Huda Zainal, Wan Shukeri Wan Fadzlina, Ibrahim Kamaruddin, Mukmin Laila Abdul
机构信息
Department of Anesthesiology and Intensive Care, Universiti Sains Malaysia, School of Medical Sciences, 16150, Kubang Kerian, Kelantan, Malaysia.
Faculty of Medicine and Health Sciences, Islamic Science University of Malaysia, Bandar Baru Nilai, 71800, Nilai, Negeri Sembilan, Malaysia.
出版信息
Int J Cardiol Congenit Heart Dis. 2022 Mar;7:100325. doi: 10.1016/j.ijcchd.2022.100325. Epub 2022 Jan 12.
Since the coronavirus disease 2019 (COVID-19) pandemic emerged in November 2019, various international guidelines and local protocols have been published to assist clinicians face the pandemic effectively. Medical and ventilatory strategies have evolved and researchers have come out with multiple studies and solutions within a short period of time. The patient's best interest is always the goal of the management. We present a case report of COVID-19 pneumonia in a patient with underlying Eisenmenger syndrome and the potential benefits of high-flow nasal oxygen therapy in this patient.
自2019年11月新型冠状病毒肺炎（COVID-19）大流行出现以来，已发布了各种国际指南和地方协议，以帮助临床医生有效应对这一疫情。医疗和通气策略不断发展，研究人员在短时间内开展了多项研究并提出了多种解决方案。始终以患者的最大利益为治疗目标。我们报告一例患有艾森曼格综合征的COVID-19肺炎患者病例，并探讨高流量鼻导管给氧疗法对该患者的潜在益处。
Zotero 插件